• Molecular NameClidinium
  • SynonymNA
  • Weight352.454
  • Drugbank_IDDB00771
  • ACS_NO7020-55-5
  • Show 2D model
  • LogP (experiment)-0.5
  • LogP (predicted, AB/LogP v2.0)-0.5
  • pkaN/A
  • LogD (pH=7, predicted)-0.5
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.62
  • LogSw (predicted, AB/LogsW2.0)80.82
  • Sw (mg/ml) (predicted, ACD/Labs)85.44
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds5
  • TPSA46.53
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn anticholinergic drug.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionRenal and biliary
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySigns of toxicity include confusion, paralytic ileus, urinary hesitancy/retention, and blurred vision.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A